LA JOLLA PHARMACEUTICAL CO Insider Trading for March 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for March 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 7.64 | 195 | 1,490 | 195 | |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 6.49 | 195 | 1,266 | 1,263,799 | 1.3 M to 1.3 M (+0.02 %) |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.64 | 122 | 932 | 122 | |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.49 | 122 | 792 | 77,714 | 77.6 K to 77.7 K (+0.16 %) |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 7.64 | 29 | 222 | 29 | |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 6.49 | 29 | 188 | 5,401 | 5.4 K to 5.4 K (+0.54 %) |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 7.64 | 49 | 374 | 49 | |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 6.49 | 49 | 318 | 1,214 | 1.2 K to 1.2 K (+4.21 %) |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 5.70 | 261 | 1,488 | 261 | |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 4.85 | 261 | 1,266 | 1,263,604 | 1.3 M to 1.3 M (+0.02 %) |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.70 | 164 | 935 | 164 | |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 4.85 | 164 | 795 | 77,592 | 77.4 K to 77.6 K (+0.21 %) |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.70 | 65 | 371 | 65 | |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 4.85 | 65 | 315 | 1,165 | 1.1 K to 1.2 K (+5.91 %) |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 5.70 | 40 | 228 | 40 | |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 4.85 | 40 | 194 | 5,372 | 5.3 K to 5.4 K (+0.75 %) |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 5.70 | 230 | 1,311 | 230 | |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 4.85 | 230 | 1,116 | 14,049 | 13.8 K to 14 K (+1.66 %) |